Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Accured Expenses: 2020-2025

Historic Change in Accured Expenses for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $71,311.

  • iSpecimen's Change in Accured Expenses rose 124.02% to $71,311 in Q3 2025 from the same period last year, while for Sep 2025 it was -$305,495, marking a year-over-year decrease of 5367.96%. This contributed to the annual value of -$371,821 for FY2024, which is 4068.63% down from last year.
  • Latest data reveals that iSpecimen reported Change in Accured Expenses of $71,311 as of Q3 2025, which was up 141.29% from -$172,687 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Change in Accured Expenses registered a high of $645,675 during Q4 2022, and its lowest value of -$2.3 million during Q2 2021.
  • Its 3-year average for Change in Accured Expenses is -$74,033, with a median of -$26,038 in 2023.
  • Per our database at Business Quant, iSpecimen's Change in Accured Expenses spiked by 98,176.26% in 2022 and then slumped by 2,164.65% in 2023.
  • Over the past 5 years, iSpecimen's Change in Accured Expenses (Quarterly) stood at $657 in 2021, then soared by 98,176.26% to $645,675 in 2022, then dropped by 20.60% to $512,647 in 2023, then slumped by 71.44% to $146,413 in 2024, then skyrocketed by 124.02% to $71,311 in 2025.
  • Its Change in Accured Expenses was $71,311 in Q3 2025, compared to -$172,687 in Q2 2025 and -$350,532 in Q1 2025.